Amelioration of ischemia-reperfusion injury in rat intestine by pentoxifylline-mediated inhibition of xanthine oxidase

被引:47
作者
Hammerman, C
Goldschmidt, D
Caplan, MS
Kaplan, M
Schimmel, MS
Eidelman, AI
Branski, D
Hochman, A
机构
[1] Shaare Zedek Med Ctr, Dept Neonatol, IL-91031 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel
[3] Northwestern Univ, Evanston Hosp, Dept Perinatal Pediat, Evanston, IL 60201 USA
[4] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel
关键词
ischemia-reperfusion; pentoxifylline; reduced glutathione; thiobarbituric acid-reducing substances; xanthine oxidase; xanthine dehydrogenase;
D O I
10.1097/00005176-199907000-00017
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Intestinal ischemia-reperfusion (IR) injury results in cell destruction, which may be mediated by the generation of reactive oxygen species, potentially toxic metabolites of xanthine oxidase. Pentoxifylline (PTX) possesses a variety of biochemical and antioxidant properties that can improve capillary now and tissue oxygenation. Because of these combined effects, it has been hypothesized that pentoxifylline would protect against intestinal IR. Methods: Young adult rats were randomly assigned to one of four experimental groups: IR/Placebo (n = 12) in which superior and inferior mesenteric arteries were clamped for 45 minutes and then reopened; IR/PTX (n = 11) in which IR was induced as in the Placebo group, but with 25 mg/kg PTX at 0, 30, and 60 minutes; No IR/Placebo (n = 12); and No IR/PTX (n = 6) in which placebo and PTX were applied with no IR. Blood and intestinal samples were taken for serial thiobarbituric acid-reducing substances (TBARS; index of lipid peroxidation), for xanthine oxidase-xanthine dehydrogenase ratios, glutathione, myeloperoxidase, and histopathology. Results: Animals in the IR/PTX group had lower TEARS and the least severe histopathologic injury. Xanthine oxidase-xanthine dehydrogenase ratios were elevated only in IR/ Placebo (0.67 +/- 0.22 vs. 0.45 +/- 0.14 in IR/PTX; 0.42 +/- 0.22 in No IR/Placebo; and 0.40 +/- 0.11 in No IR/PTX; p = 0.0009). Reduced glutathione was diminished in IR/PTX animals (38.9 +/- 1.35 vs. 46.1 +/- 7.0 in IR/Placebo; 41.1 +/- 2.5 in No IR/ Placebo; 43.6 +/- 1.0 in No IR/PTX; p = 0.048). No differences were recorded in myeloperoxidase levels among groups. Conclusions: Pentoxifylline ameliorates histopathologic signs of injury and decreases lipid peroxidation (TBARS). Normal xanthine oxidase-xanthine dehydrogenase ratios in the treated compared with IR-only animals imply that the protective effect of PTX is at least partially mediated through inhibition of xanthine oxidase.
引用
收藏
页码:69 / 74
页数:6
相关论文
共 34 条
[1]  
ADAMS JD, 1983, J PHARMACOL EXP THER, V227, P749
[2]   A NOVEL MECHANISM FOR THE GENERATION OF SUPEROXIDE ANIONS IN HEMATOPORPHYRIN DERIVATIVE MEDIATED CUTANEOUS PHOTOSENSITIZATION - ACTIVATION OF THE XANTHINE-OXIDASE PATHWAY [J].
ATHAR, M ;
ELMETS, CA ;
BICKERS, DR ;
MUKHTAR, H .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) :1137-1143
[3]   Glutamate neurotoxicity in rat cerebellar granule cells: A major role for xanthine oxidase in oxygen radical formation [J].
Atlante, A ;
Gagliardi, S ;
Minervini, GM ;
Ciotti, MT ;
Marra, E ;
Calissano, P .
JOURNAL OF NEUROCHEMISTRY, 1997, 68 (05) :2038-2045
[4]   alpha(2)-adrenergic agonists reduce glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices during hypoxia [J].
Bickler, PE ;
Hansen, BM .
NEUROPHARMACOLOGY, 1996, 35 (06) :679-687
[5]  
BICKLER PE, 1995, BRAIN RES, V665, P296
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   THE 2ND MESSENGER LINKING RECEPTOR ACTIVATION TO INTERNAL CA RELEASE IN LIVER [J].
BURGESS, GM ;
GODFREY, PP ;
MCKINNEY, JS ;
BERRIDGE, MJ ;
IRVINE, RF ;
PUTNEY, JW .
NATURE, 1984, 309 (5963) :63-66
[8]  
CLARK DA, 1988, AM J PATHOL, V130, P537
[9]   ROLE OF OXYGEN DERIVED FREE-RADICALS IN PLATELET ACTIVATING FACTOR INDUCED BOWEL NECROSIS [J].
CUEVA, JP ;
HSUEH, W .
GUT, 1988, 29 (09) :1207-1212
[10]   CLINICAL-PHARMACOLOGY OF PENTOXIFYLLINE WITH SPECIAL REFERENCE TO ITS HEMORRHEOLOGIC EFFECT FOR THE TREATMENT OF INTERMITTENT CLAUDICATION [J].
DETTELBACH, HR ;
AVIADO, DM .
JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (01) :8-26